Indications and uses
Temporarily relieves: occasional minor irritation, pain, sore throat and sore mouth
Chloraseptic Sore Throat Liquid Center
- Manufacturer
- Prestige Brands Holdings, Inc. | BestSweet, Inc.
- Effective date
- 2010-11-19
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:26:23
Label at a glance#
ProductChloraseptic Sore Throat Liquid Center
Active ingredientMENTHOL, BENZOCAINE
Label structure34 sections
Dosage and administration
Adults and children 6 years of age and over: Take 1 lozenge every 2 hours as needed. Allow lozenges to dissolve slowly in the mouth. Children under 6 years of age: Consult a doctor or dentist.
Contacts and useful links#
Websitewww.chloraseptic.com
www.chloraseptic.com
www.chloraseptic.comLabel contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
Chloraseptic Cherry Lozenges
Active Ingredients
(in each lozenge)
Benzocaine 6 mg
Purpose
Oral Anesthetic/Analgesic
Active Ingredients
(in each lozenge)
Menthol 10 mg
Purpose
Oral Anesthetic/Analgesic
Uses
Temporarily relieves:
- occasional minor irritation, pain, sore throat and sore mouth
Warnings
Allergy Alert: Do not use this product if you have a history of allergy to local anesthetics such as procaine, butacaine, benzocaine or other “caine” anesthetics.
Sore Throat Warning: Severe or persistent sore throat or sore throat accompanied by high fever, headache, nausea and vomiting may be serious. Consult a doctor promptly. Do not use more than 2 days or administer to children under 6 years of age unless directed by a doctor.
When using this product:
do not exceed recommended dosage.
Stop use and ask a dentist or doctor if:
- sore mouth symptoms do not improve in 7 days
- irritation, pain or redness persists or worsens
- swelling, rash or fever develops
If pregnant or breast-feeding,
ask a health care professional before use.
Keep out of reach of children.
In case of overdose or accidental poisoning, get medical help or contact a Poison Control Center right away.
Directions
- Adults and children 6 years of age and over: Take 1 lozenge every 2 hours as needed. Allow lozenges to dissolve slowly in the mouth.
- Children under 6 years of age: Consult a doctor or dentist.
Other Information
- Store between 59ºF and 86ºF (15ºC - 30ºC).
- Protect from moisture.
- Check expiration date before using.
- Tamper Evident: Do not use if blister package with “Chloraseptic®” name has been disturbed or opened.
Inactive Ingredients
Corn Syrup, FD&C Red #40, Flavor, Glycerine, Soy Lecithin, Sucrose, Water
Questions?
Active Ingredients
(in each lozenge)
Benzocaine 6 mg
Purpose
Oral Anesthetic/Analgesic
Active Ingredients
(in each lozenge)
Menthol 10 mg
Purpose
Oral Anesthetic/Analgesic
Uses
Temporarily relieves:
- occasional minor irritation, pain, sore throat and sore mouth
Warnings
Allergy Alert: Do not use this product if you have a history of allergy to local anesthetics such as procaine, butacaine, benzocaine or other “caine” anesthetics.
Sore Throat Warning: Severe or persistent sore throat or sore throat accompanied by high fever, headache, nausea and vomiting may be serious. Consult a doctor promptly. Do not use more than 2 days or administer to children under 6 years of age unless directed by a doctor.
When using this product:
do not exceed recommended dosage.
Stop use and ask a dentist or doctor if:
- sore mouth symptoms do not improve in 7 days
- irritation, pain or redness persists or worsens
- swelling, rash or fever develops
If pregnant or breast-feeding,
ask a health care professional before use.
Keep out of reach of children.
In case of overdose or accidental poisoning, get medical help or contact a Poison Control Center right away.
Directions
- Adults and children 6 years of age and over: Take 1 lozenge every 2 hours as needed. Allow lozenges to dissolve slowly in the mouth.
- Children under 6 years of age: Consult a doctor or dentist.
Other Information
- Store between 59ºF and 86ºF (15ºC - 30ºC).
- Protect from moisture.
- Check expiration date before using.
- Tamper Evident: Do not use if blister package with “Chloraseptic®” name has been disturbed or opened.
Inactive Ingredients
Corn Syrup, FD&C Red #40, FD&C Yellow #6, Flavor, Glycerine, Propylene Glycol, Soy Lecithin, Sucrose, Water
Questions?
Active Ingredients
(in each lozenge)
Benzocaine 6 mg
Purpose
Oral Anesthetic/Analgesic
Active Ingredients
(in each lozenge)
Menthol 10 mg
Purpose
Oral Anesthetic/Analgesic
Uses
Temporarily relieves:
- occasional minor irritation, pain, sore throat and sore mouth
Warnings
Allergy Alert: Do not use this product if you have a history of allergy to local anesthetics such as procaine, butacaine, benzocaine or other “caine” anesthetics.
Sore Throat Warning: Severe or persistent sore throat or sore throat accompanied by high fever, headache, nausea and vomiting may be serious. Consult a doctor promptly. Do not use more than 2 days or administer to children under 6 years of age unless directed by a doctor.
When using this product:
do not exceed recommended dosage.
Stop use and ask a dentist or doctor if:
- sore mouth symptoms do not improve in 7 days
- irritation, pain or redness persists or worsens
- swelling, rash or fever develops
If pregnant or breast-feeding,
ask a health care professional before use.
Keep out of reach of children.
In case of overdose or accidental poisoning, get medical help or contact a Poison Control Center right away.
Directions
- Adults and children 6 years of age and over: Take 1 lozenge every 2 hours as needed. Allow lozenges to dissolve slowly in the mouth.
- Children under 6 years of age: Consult a doctor or dentist.
Other Information
- Store between 59ºF and 86ºF (15ºC - 30ºC).
- Protect from moisture.
- Check expiration date before using.
- Tamper Evident: Do not use if blister package with “Chloraseptic®” name has been disturbed or opened.
Inactive Ingredients
Corn Syrup, FD&C Yellow #5, Flavor, Glycerine, Honey, Propylene Glycol, Soy Lecithin, Sucrose, Water
Questions?
1-800-552-7932 or www.chloraseptic.com
PRINCIPAL DISPLAY PANEL
Chloraseptic®
SORE THROAT
18 lozenges | Cherry
PRINCIPAL DISPLAY PANEL
Chloraseptic®
SORE THROAT
18 lozenges | Citrus
PRINCIPAL DISPLAY PANEL
Chloraseptic®
SORE THROAT
18 lozenges | Honey Lemon with real honey
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 308668 | benzocaine 6 MG / menthol 10 MG Oral Lozenge | PSN | 1 |
| 802559 | Chloraseptic Sore Throat 10 MG / 6 MG Oral Lozenge | PSN | 1 |
| 802559 | benzocaine 6 MG / menthol 10 MG Oral Lozenge [Chloraseptic Sore Throat] | SBD | 1 |
| 308668 | benzocaine 6 MG / menthol 10 MG Oral Lozenge | SCD | 1 |
| 802559 | Chloraseptic Sore Throat (benzocaine 6 MG / menthol 10 MG) Oral Lozenge | SY | 1 |
| 802559 | Chloraseptic Sore Throat Oral Lozenge | SY | 1 |
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| BENZOCAINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 67172-011-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-f872-f424-e053-dadaa90a57ce | Chloraseptic Cherry Honey Lemon and Citrus Lozenges |
| 67172-012-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-f872-f424-e053-dadaa90a57ce | Chloraseptic Cherry Honey Lemon and Citrus Lozenges |
| 67172-013-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-f872-f424-e053-dadaa90a57ce | Chloraseptic Cherry Honey Lemon and Citrus Lozenges |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67172-011-01 | Chloraseptic Sore Throat Liquid Center | 1 in 1 CARTON | LOZENGE | 1 | 1 | |
| 67172-011-01 | Chloraseptic Sore Throat Liquid Center | 18 in 1 BLISTER PACK | LOZENGE | 18 | 1 | |
| 67172-012-01 | Chloraseptic Sore Throat Liquid Center | 1 in 1 CARTON | LOZENGE | 1 | 1 | |
| 67172-012-01 | Chloraseptic Sore Throat Liquid Center | 18 in 1 BLISTER PACK | LOZENGE | 18 | 1 | |
| 67172-013-01 | Chloraseptic Sore Throat Liquid Center | 18 in 1 BLISTER PACK | LOZENGE | 18 | 1 | |
| 67172-013-01 | Chloraseptic Sore Throat Liquid Center | 1 in 1 CARTON | LOZENGE | 1 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 67172-011 | CHLORASEPTIC SORE THROAT LIQUID CENTER (MENTHOL AND BENZOCAINE) LOZENGE [PRESTIGE BRANDS HOLDINGS, INC.] | 1 | Legacy NDC, 2 package rows | 20101117_dfb0c915-458e-4af5-8a33-38b768980c90.zip |
| 67172-012 | CHLORASEPTIC SORE THROAT LIQUID CENTER (MENTHOL AND BENZOCAINE) LOZENGE [PRESTIGE BRANDS HOLDINGS, INC.] | 1 | Legacy NDC, 2 package rows | 20101117_dfb0c915-458e-4af5-8a33-38b768980c90.zip |
| 67172-013 | CHLORASEPTIC SORE THROAT LIQUID CENTER (MENTHOL AND BENZOCAINE) LOZENGE [PRESTIGE BRANDS HOLDINGS, INC.] | 1 | Legacy NDC, 2 package rows | 20101117_dfb0c915-458e-4af5-8a33-38b768980c90.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| BENZOCAINE | ACTIVE INGREDIENT | U3RSY48JW5 | 1 | |
| MENTHOL | ACTIVE INGREDIENT | L7T10EIP3A | 1 | |
| BENZOCAINE | ACTIVE MOIETY | U3RSY48JW5 | 1 | |
| MENTHOL | ACTIVE MOIETY | L7T10EIP3A | 1 | |
| CORN SYRUP | INACTIVE INGREDIENT | 9G5L16BK6N | 1 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | 1 | |
| FD&C YELLOW NO. 5 | INACTIVE INGREDIENT | I753WB2F1M | 1 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| HONEY | INACTIVE INGREDIENT | Y9H1V576FH | 1 | |
| LECITHIN, SOYBEAN | INACTIVE INGREDIENT | 1DI56QDM62 | 1 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | 1 | |
| SUCRALOSE | INACTIVE INGREDIENT | 96K6UQ3ZD4 | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- Chloraseptic Sore Throat Liquid Center
- Menthol and Benzocaine
- MENTHOL
- BENZOCAINE
- CORN SYRUP
- FD&C RED NO. 40
- GLYCERIN
- LECITHIN, SOYBEAN
- SUCRALOSE
- WATER
- FD&C YELLOW NO. 6
- PROPYLENE GLYCOL
- FD&C YELLOW NO. 5
- HONEY
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 67172-011 | 67172-011-01 |
| 67172-012 | 67172-012-01 |
| 67172-013 | 67172-013-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| MENTHOL | L7T10EIP3A | ACTIB |
| BENZOCAINE | U3RSY48JW5 | ACTIB |
| CORN SYRUP | 9G5L16BK6N | IACT |
| FD&C RED NO. 40 | WZB9127XOA | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| LECITHIN, SOYBEAN | 1DI56QDM62 | IACT |
| SUCRALOSE | 96K6UQ3ZD4 | IACT |
| WATER | 059QF0KO0R | IACT |
| MENTHOL | L7T10EIP3A | ACTIB |
| BENZOCAINE | U3RSY48JW5 | ACTIB |
| CORN SYRUP | 9G5L16BK6N | IACT |
| FD&C RED NO. 40 | WZB9127XOA | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| LECITHIN, SOYBEAN | 1DI56QDM62 | IACT |
| SUCRALOSE | 96K6UQ3ZD4 | IACT |
| WATER | 059QF0KO0R | IACT |
| FD&C YELLOW NO. 6 | H77VEI93A8 | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| MENTHOL | L7T10EIP3A | ACTIB |
| BENZOCAINE | U3RSY48JW5 | ACTIB |
| CORN SYRUP | 9G5L16BK6N | IACT |
| LECITHIN, SOYBEAN | 1DI56QDM62 | IACT |
| SUCRALOSE | 96K6UQ3ZD4 | IACT |
| WATER | 059QF0KO0R | IACT |
| FD&C YELLOW NO. 5 | I753WB2F1M | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| HONEY | Y9H1V576FH | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, SOLUTION / INTRAVENOUS | 4000 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION, EXTENDED RELEASE / ORAL | 1000 mg | ||
| FD&C YELLOW NO. 5 | FD&C YELLOW NO. 5 | I753WB2F1M | POWDER / TOPICAL | NA | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | SYRUP / ORAL | 80 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | FILM, SOLUBLE / ORAL | 33 mg | ||
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | TABLET / SUBLINGUAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION/ DROPS / OPHTHALMIC | 0.75 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION / INTRAVENOUS | 16624 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | TABLET / SUBLINGUAL | 12 mg | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | POWDER, FOR SOLUTION / ORAL | 40 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / DENTAL | 2 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SWAB / TOPICAL | 34.6 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| FD&C YELLOW NO. 5 | FD&C YELLOW NO. 5 | I753WB2F1M | LIQUID / ORAL | NA | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / RECTAL | 27 mg | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | ELIXIR / ORAL | 5.4 mg/5ml | ||
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | CONCENTRATE / ORAL | 0.04 mg/1ml | ||
| CORN SYRUP | CORN SYRUP | 9G5L16BK6N | SUSPENSION, EXTENDED RELEASE / ORAL | 1500 mg/5ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| FD&C YELLOW NO. 5 | FD&C YELLOW NO. 5 | I753WB2F1M | ELIXIR / ORAL | 0.15 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | LOTION, AUGMENTED / TOPICAL | 2070 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | FILM / ORAL | 1 mg | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | MOUTHWASH / BUCCAL | 0.01 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | TABLET, ORALLY DISINTEGRATING / ORAL | 60 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / DENTAL | NA | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION / SUBCUTANEOUS | 1.4 %w/v | ||
| FD&C YELLOW NO. 5 | FD&C YELLOW NO. 5 | I753WB2F1M | OINTMENT / TOPICAL | 0.01 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION, CONCENTRATE / ORAL | 2590 mg | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | CAPSULE, LIQUID FILLED / ORAL | 1 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / RESPIRATORY (INHALATION) | 25 %w/w | ||
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | SUSPENSION/ DROPS / ORAL | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / DENTAL | 15 %w/v | ||
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | SPONGE / TOPICAL | NA | ||
| FD&C YELLOW NO. 5 | FD&C YELLOW NO. 5 | I753WB2F1M | TABLET / ORAL | 180 mg | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | TABLET, COATED / ORAL | 3.17 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / OPHTHALMIC | 6 %w/v | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | GUM, CHEWING / BUCCAL | 70 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, EXTENDED RELEASE / ORAL | 265 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, EXTENDED RELEASE / ORAL | 9 mg | ||
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | GUM, CHEWING / BUCCAL | 48 mg | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | TABLET, FILM COATED / ORAL | 1 mg | ||
| CORN SYRUP | CORN SYRUP | 9G5L16BK6N | TABLET / ORAL | 14.07 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | GRANULE / ORAL | 5.4 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, FOAM / RECTAL | 1214 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | LIQUID / ORAL | 29008 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / OPHTHALMIC | 0.6 %w/v |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| a168aa95-402e-4476-ba95-f267d4d86684 | dfb0c915-458e-4af5-8a33-38b768980c90 | 2010-11-19 | Warnings | a168aa95-402e-4476-ba95-f267d4d86684 dfb0c915-458e-4af5-8a33-38b768980c90 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.